| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Menorrhagia | 10 | 2023 | 18 | 3.850 |
Why?
|
| Uterine Hemorrhage | 12 | 2020 | 20 | 3.180 |
Why?
|
| Hysterectomy | 11 | 2023 | 69 | 2.880 |
Why?
|
| Menstruation | 8 | 2023 | 34 | 2.500 |
Why?
|
| Intrauterine Devices, Medicated | 4 | 2023 | 7 | 1.980 |
Why?
|
| Practice Patterns, Physicians' | 11 | 2025 | 708 | 1.910 |
Why?
|
| Gynecology | 8 | 2025 | 55 | 1.570 |
Why?
|
| Menstruation Disturbances | 7 | 2023 | 18 | 1.540 |
Why?
|
| Quality of Life | 12 | 2023 | 1257 | 1.430 |
Why?
|
| Surveys and Questionnaires | 11 | 2020 | 2737 | 1.430 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 531 | 1.410 |
Why?
|
| Obstetrics | 7 | 2025 | 90 | 1.400 |
Why?
|
| Female | 68 | 2025 | 33360 | 1.200 |
Why?
|
| Contraception | 6 | 2025 | 71 | 1.160 |
Why?
|
| Emergency Service, Hospital | 5 | 2017 | 1118 | 1.090 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 170 | 1.070 |
Why?
|
| Gynecologic Surgical Procedures | 4 | 2023 | 47 | 0.950 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 513 | 0.890 |
Why?
|
| Humans | 69 | 2025 | 64252 | 0.830 |
Why?
|
| Adult | 33 | 2025 | 17121 | 0.820 |
Why?
|
| Women's Health | 5 | 2020 | 374 | 0.800 |
Why?
|
| Laparoscopy | 5 | 2023 | 483 | 0.800 |
Why?
|
| Endometrial Ablation Techniques | 2 | 2014 | 6 | 0.790 |
Why?
|
| Acute Pain | 1 | 2023 | 21 | 0.770 |
Why?
|
| Pregnancy | 18 | 2023 | 2370 | 0.770 |
Why?
|
| Levonorgestrel | 4 | 2024 | 10 | 0.770 |
Why?
|
| Endometrial Neoplasms | 2 | 2023 | 64 | 0.740 |
Why?
|
| Young Adult | 15 | 2023 | 4780 | 0.660 |
Why?
|
| Postmenopause | 2 | 2019 | 238 | 0.660 |
Why?
|
| Cross-Sectional Studies | 15 | 2025 | 2621 | 0.630 |
Why?
|
| Penicillins | 2 | 2010 | 30 | 0.620 |
Why?
|
| Attitude of Health Personnel | 6 | 2018 | 620 | 0.610 |
Why?
|
| Cesarean Section | 1 | 2020 | 104 | 0.600 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2023 | 5 | 0.600 |
Why?
|
| Streptococcus agalactiae | 2 | 2010 | 79 | 0.590 |
Why?
|
| Streptococcal Infections | 2 | 2010 | 80 | 0.590 |
Why?
|
| Preventive Health Services | 1 | 2019 | 75 | 0.590 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2019 | 29 | 0.590 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2010 | 65 | 0.590 |
Why?
|
| Uterine Diseases | 3 | 2019 | 9 | 0.590 |
Why?
|
| Intrauterine Devices | 3 | 2025 | 8 | 0.590 |
Why?
|
| Lactation | 1 | 2019 | 70 | 0.580 |
Why?
|
| Physicians | 2 | 2017 | 483 | 0.570 |
Why?
|
| Prenatal Care | 2 | 2017 | 174 | 0.550 |
Why?
|
| Postoperative Complications | 4 | 2017 | 1294 | 0.550 |
Why?
|
| Rhode Island | 6 | 2025 | 104 | 0.540 |
Why?
|
| Nurses | 1 | 2019 | 109 | 0.540 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 146 | 0.540 |
Why?
|
| Delivery, Obstetric | 2 | 2017 | 53 | 0.540 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2019 | 771 | 0.530 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 16 | 0.530 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2023 | 126 | 0.520 |
Why?
|
| Cohort Studies | 9 | 2023 | 2604 | 0.510 |
Why?
|
| Prisoners | 1 | 2019 | 173 | 0.510 |
Why?
|
| Contraceptive Agents, Female | 2 | 2019 | 24 | 0.500 |
Why?
|
| Postpartum Period | 2 | 2021 | 196 | 0.500 |
Why?
|
| Drug Utilization | 1 | 2018 | 208 | 0.500 |
Why?
|
| Retrospective Studies | 13 | 2024 | 6732 | 0.470 |
Why?
|
| Promethazine | 1 | 2015 | 2 | 0.460 |
Why?
|
| Prochlorperazine | 1 | 2015 | 5 | 0.460 |
Why?
|
| Morning Sickness | 1 | 2015 | 2 | 0.460 |
Why?
|
| Metoclopramide | 1 | 2015 | 12 | 0.460 |
Why?
|
| Insurance, Health | 1 | 2016 | 151 | 0.460 |
Why?
|
| Language | 1 | 2016 | 150 | 0.450 |
Why?
|
| Ondansetron | 1 | 2015 | 33 | 0.450 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 161 | 0.450 |
Why?
|
| Metrorrhagia | 1 | 2014 | 4 | 0.440 |
Why?
|
| Middle Aged | 17 | 2025 | 17906 | 0.420 |
Why?
|
| Antiemetics | 1 | 2015 | 96 | 0.420 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2010 | 55 | 0.410 |
Why?
|
| Adolescent | 13 | 2023 | 6304 | 0.410 |
Why?
|
| Drug Hypersensitivity | 2 | 2010 | 28 | 0.400 |
Why?
|
| Pregnancy, Tubal | 1 | 2013 | 1 | 0.390 |
Why?
|
| Length of Stay | 2 | 2015 | 818 | 0.390 |
Why?
|
| Referral and Consultation | 1 | 2016 | 428 | 0.390 |
Why?
|
| Leiomyoma | 3 | 2020 | 18 | 0.390 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 293 | 0.390 |
Why?
|
| Uterine Neoplasms | 3 | 2020 | 35 | 0.380 |
Why?
|
| Health Status | 2 | 2013 | 447 | 0.380 |
Why?
|
| Self Report | 1 | 2015 | 388 | 0.370 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1561 | 0.370 |
Why?
|
| United States | 13 | 2023 | 7923 | 0.360 |
Why?
|
| Hypertension | 1 | 2017 | 593 | 0.360 |
Why?
|
| Vaginal Diseases | 1 | 2011 | 7 | 0.360 |
Why?
|
| Prevalence | 6 | 2020 | 1407 | 0.360 |
Why?
|
| Menopause | 1 | 2014 | 260 | 0.360 |
Why?
|
| Health Care Costs | 1 | 2013 | 215 | 0.350 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 16 | 0.350 |
Why?
|
| Medical History Taking | 1 | 2011 | 68 | 0.350 |
Why?
|
| Uterine Artery Embolization | 2 | 2010 | 4 | 0.350 |
Why?
|
| Postal Service | 1 | 2010 | 6 | 0.340 |
Why?
|
| Pain | 1 | 2014 | 407 | 0.340 |
Why?
|
| Pregnancy, Unplanned | 3 | 2016 | 21 | 0.340 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2016 | 96 | 0.330 |
Why?
|
| Health Care Surveys | 2 | 2010 | 289 | 0.330 |
Why?
|
| Anemia | 1 | 2012 | 128 | 0.330 |
Why?
|
| Pain Measurement | 3 | 2020 | 348 | 0.320 |
Why?
|
| Menstrual Cycle | 3 | 2025 | 82 | 0.310 |
Why?
|
| Prospective Studies | 5 | 2022 | 3316 | 0.290 |
Why?
|
| Obesity | 2 | 2014 | 1247 | 0.290 |
Why?
|
| Treatment Outcome | 8 | 2023 | 5691 | 0.290 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 267 | 0.280 |
Why?
|
| Attitude to Health | 3 | 2008 | 294 | 0.280 |
Why?
|
| Patient Discharge | 2 | 2023 | 507 | 0.280 |
Why?
|
| Women's Health Services | 1 | 2008 | 30 | 0.270 |
Why?
|
| Ambulatory Care | 2 | 2021 | 317 | 0.270 |
Why?
|
| Logistic Models | 3 | 2016 | 1270 | 0.260 |
Why?
|
| Internet | 1 | 2010 | 467 | 0.260 |
Why?
|
| Dysmenorrhea | 3 | 2023 | 8 | 0.260 |
Why?
|
| Sexual Behavior | 4 | 2016 | 195 | 0.260 |
Why?
|
| Hospital Charges | 1 | 2006 | 22 | 0.250 |
Why?
|
| Pregnancy Rate | 1 | 2006 | 31 | 0.240 |
Why?
|
| Risk Factors | 5 | 2014 | 5339 | 0.230 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 321 | 0.230 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 788 | 0.230 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2017 | 13 | 0.230 |
Why?
|
| Mothers | 2 | 2019 | 276 | 0.230 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2022 | 788 | 0.230 |
Why?
|
| Salpingectomy | 2 | 2016 | 5 | 0.230 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 1103 | 0.220 |
Why?
|
| Clinical Trials as Topic | 2 | 2025 | 460 | 0.220 |
Why?
|
| Menstrual Hygiene Products | 2 | 2023 | 5 | 0.220 |
Why?
|
| Endometrium | 3 | 2020 | 31 | 0.200 |
Why?
|
| Endrin | 1 | 2023 | 4 | 0.200 |
Why?
|
| Progesterone | 1 | 2024 | 163 | 0.200 |
Why?
|
| Hematologic Diseases | 1 | 2023 | 12 | 0.200 |
Why?
|
| Physician-Patient Relations | 2 | 2017 | 424 | 0.200 |
Why?
|
| Prescriptions | 1 | 2023 | 33 | 0.200 |
Why?
|
| Oxycodone | 1 | 2023 | 30 | 0.190 |
Why?
|
| Cost of Illness | 2 | 2015 | 169 | 0.190 |
Why?
|
| Endometriosis | 2 | 2020 | 28 | 0.190 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 575 | 0.190 |
Why?
|
| Aftercare | 1 | 2023 | 75 | 0.190 |
Why?
|
| Sickness Impact Profile | 2 | 2015 | 46 | 0.190 |
Why?
|
| Mental Disorders | 2 | 2020 | 794 | 0.190 |
Why?
|
| Internship and Residency | 2 | 2024 | 808 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 800 | 0.180 |
Why?
|
| Abdominal Pain | 2 | 2013 | 101 | 0.180 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 48 | 0.170 |
Why?
|
| Simulation Training | 1 | 2022 | 66 | 0.170 |
Why?
|
| Tobacco Smoking | 1 | 2020 | 20 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2016 | 2047 | 0.160 |
Why?
|
| Marijuana Use | 1 | 2020 | 22 | 0.160 |
Why?
|
| Prognosis | 3 | 2014 | 1769 | 0.160 |
Why?
|
| Smoking Water Pipes | 1 | 2019 | 6 | 0.150 |
Why?
|
| Water Pipe Smoking | 1 | 2019 | 9 | 0.150 |
Why?
|
| Tobacco, Waterpipe | 1 | 2019 | 8 | 0.150 |
Why?
|
| Health Literacy | 1 | 2020 | 86 | 0.150 |
Why?
|
| Flavoring Agents | 1 | 2019 | 15 | 0.150 |
Why?
|
| Linear Models | 1 | 2020 | 407 | 0.150 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2019 | 3 | 0.150 |
Why?
|
| Hospitals, Maternity | 1 | 2019 | 10 | 0.150 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2019 | 12 | 0.150 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 299 | 0.150 |
Why?
|
| Desogestrel | 1 | 2019 | 4 | 0.150 |
Why?
|
| Outpatients | 1 | 2020 | 140 | 0.150 |
Why?
|
| Tobacco Products | 1 | 2020 | 62 | 0.150 |
Why?
|
| Research Design | 3 | 2025 | 583 | 0.150 |
Why?
|
| Global Health | 1 | 2020 | 183 | 0.150 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2019 | 19 | 0.150 |
Why?
|
| Patient Satisfaction | 3 | 2013 | 438 | 0.150 |
Why?
|
| Papanicolaou Test | 1 | 2019 | 45 | 0.150 |
Why?
|
| Postnatal Care | 1 | 2019 | 43 | 0.150 |
Why?
|
| Vaginal Smears | 1 | 2019 | 58 | 0.150 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 72 | 0.150 |
Why?
|
| Male | 9 | 2025 | 30305 | 0.140 |
Why?
|
| Prisons | 1 | 2019 | 114 | 0.140 |
Why?
|
| Medicaid | 1 | 2021 | 362 | 0.140 |
Why?
|
| Inpatients | 1 | 2020 | 303 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 214 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 316 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 984 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2018 | 203 | 0.120 |
Why?
|
| Ovariectomy | 1 | 2016 | 103 | 0.120 |
Why?
|
| Terminology as Topic | 2 | 2020 | 141 | 0.120 |
Why?
|
| Vaccination | 3 | 2024 | 371 | 0.120 |
Why?
|
| Emergencies | 1 | 2016 | 121 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 226 | 0.120 |
Why?
|
| Contraception Behavior | 1 | 2016 | 37 | 0.120 |
Why?
|
| Ketosis | 1 | 2015 | 3 | 0.110 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 25 | 0.110 |
Why?
|
| Hypotension, Orthostatic | 1 | 2015 | 27 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 726 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 155 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 2480 | 0.110 |
Why?
|
| Universities | 1 | 2016 | 164 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 54 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 759 | 0.110 |
Why?
|
| School Admission Criteria | 1 | 2014 | 8 | 0.110 |
Why?
|
| Sterilization, Tubal | 1 | 2014 | 11 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2014 | 200 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 260 | 0.100 |
Why?
|
| Aged | 4 | 2020 | 14657 | 0.100 |
Why?
|
| Mass Screening | 1 | 2019 | 693 | 0.100 |
Why?
|
| Tranexamic Acid | 1 | 2013 | 7 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2019 | 539 | 0.100 |
Why?
|
| Reoperation | 1 | 2014 | 291 | 0.100 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 16 | 0.100 |
Why?
|
| Medical Records | 1 | 2013 | 138 | 0.100 |
Why?
|
| Age Distribution | 1 | 2013 | 258 | 0.100 |
Why?
|
| Health Services | 1 | 2013 | 82 | 0.100 |
Why?
|
| Reproductive Health | 1 | 2013 | 25 | 0.100 |
Why?
|
| Psychometrics | 1 | 2015 | 385 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 135 | 0.100 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 744 | 0.090 |
Why?
|
| Health Surveys | 1 | 2013 | 314 | 0.090 |
Why?
|
| Computer Communication Networks | 1 | 2011 | 12 | 0.090 |
Why?
|
| International Cooperation | 1 | 2011 | 90 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 205 | 0.090 |
Why?
|
| Educational Status | 3 | 2008 | 278 | 0.090 |
Why?
|
| Patient Selection | 2 | 2016 | 487 | 0.080 |
Why?
|
| Perioperative Care | 1 | 2011 | 86 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2013 | 486 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 909 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 147 | 0.080 |
Why?
|
| Communication | 1 | 2014 | 587 | 0.080 |
Why?
|
| Vagina | 1 | 2009 | 87 | 0.070 |
Why?
|
| Focus Groups | 1 | 2010 | 310 | 0.070 |
Why?
|
| Comorbidity | 1 | 2012 | 1118 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2010 | 306 | 0.070 |
Why?
|
| Contraception, Postcoital | 1 | 2008 | 4 | 0.070 |
Why?
|
| Health Services Misuse | 1 | 2008 | 18 | 0.070 |
Why?
|
| Condoms | 1 | 2008 | 48 | 0.070 |
Why?
|
| Family Planning Services | 1 | 2008 | 21 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 1569 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 76 | 0.070 |
Why?
|
| Incidence | 1 | 2011 | 1383 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2008 | 84 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2008 | 209 | 0.060 |
Why?
|
| Urban Population | 1 | 2008 | 198 | 0.060 |
Why?
|
| Triage | 1 | 2008 | 128 | 0.060 |
Why?
|
| Reproductive History | 1 | 2006 | 17 | 0.060 |
Why?
|
| Congresses as Topic | 2 | 2020 | 79 | 0.060 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 65 | 0.060 |
Why?
|
| Maternal Age | 1 | 2006 | 33 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 169 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 479 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2010 | 728 | 0.060 |
Why?
|
| Intrauterine Device Expulsion | 1 | 2024 | 2 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1683 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2006 | 362 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 53 | 0.050 |
Why?
|
| Informed Consent | 1 | 2023 | 141 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 102 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2006 | 872 | 0.050 |
Why?
|
| Arkansas | 1 | 2021 | 4 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2023 | 274 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 358 | 0.040 |
Why?
|
| Adenomyosis | 1 | 2020 | 1 | 0.040 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2020 | 5 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2020 | 26 | 0.040 |
Why?
|
| Uterus | 1 | 2020 | 42 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2023 | 1131 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 41 | 0.040 |
Why?
|
| Education | 1 | 2020 | 69 | 0.040 |
Why?
|
| Attitude | 1 | 2020 | 102 | 0.040 |
Why?
|
| Developing Countries | 1 | 2020 | 94 | 0.040 |
Why?
|
| Regeneration | 1 | 2020 | 101 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2020 | 122 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2022 | 482 | 0.040 |
Why?
|
| New York City | 1 | 2019 | 91 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 174 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2020 | 144 | 0.040 |
Why?
|
| Stem Cells | 1 | 2020 | 262 | 0.040 |
Why?
|
| Microbiota | 1 | 2020 | 136 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 178 | 0.040 |
Why?
|
| Income | 1 | 2019 | 172 | 0.040 |
Why?
|
| Poverty | 1 | 2020 | 299 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2020 | 270 | 0.030 |
Why?
|
| Risk-Taking | 2 | 2008 | 162 | 0.030 |
Why?
|
| Mental Health | 1 | 2020 | 372 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 16 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 2019 | 0.030 |
Why?
|
| Contraceptive Agents | 1 | 2016 | 12 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 5527 | 0.030 |
Why?
|
| Sex Education | 1 | 2016 | 25 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 1375 | 0.030 |
Why?
|
| Students | 1 | 2016 | 222 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1431 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 384 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2010 | 75 | 0.020 |
Why?
|
| Patient Preference | 1 | 2010 | 88 | 0.020 |
Why?
|
| Contraception, Barrier | 1 | 2008 | 1 | 0.020 |
Why?
|
| Sterilization | 1 | 2008 | 15 | 0.020 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2008 | 17 | 0.020 |
Why?
|
| Pregnancy, Unwanted | 1 | 2008 | 9 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 45 | 0.020 |
Why?
|
| Feedback | 1 | 2008 | 93 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2008 | 99 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 272 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2010 | 728 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 478 | 0.010 |
Why?
|